Document |
Document Title |
WO/2002/036579A1 |
The invention relates generally to pyrimidines and triazines ultraviolet light abosrbers containing a phenolic aromatic groups(s) and a non-phenolic aromatic groups(s) and the use thereof to protect agains degradation by environmental fo...
|
WO/2002/034730A1 |
The invention relates to a method for producing melamine by means of pyrolysis of urea in a high-pressure reactor with a vertical centre tube, wherein the melamine flows from the bottom to the top of the reactor, is mixed in the lower pa...
|
WO/2002/030913A1 |
A compound of formula (1) and its use as fluidising agents for dispersions of particulate solids in a polar liquid, such as water, wherein R?1¿, R?2¿ and R?3¿ are each, independently, aryl, heteroaryl or alkyl, all of which may be opt...
|
WO2001096282B1 |
The invention relates to a method for producing amides or esters from carboxylic acids and from an amine constituent or alcohol constituent in the presence of a 1,3,5-triazine and optionally in the presence of an organic solvent and of a...
|
WO/2002/022589A1 |
A method for purifying melamine comprising impurities like ureido-melamine, oxotriazines, melam, melem, comprises the step of putting into contact at a temperature comprised between 340 °C and 410 °C and at a pressure comprised between...
|
WO/2002/014288A1 |
The invention relates to the use of a special derivative of triazinetriones for combating coccidiosis in animals, particularly pigs.
|
WO/2002/013831A1 |
The invention relates to the use of special derivatives of triazinetriones for controlling coccidioses in animals, especially in pigs.
|
WO/2002/014289A1 |
Process for the preparation of melamine from urea by reacting urea or thermal decomposition products thereof at elevated temperature in the presence of a catalyst, with process condensate being discharged from the process and characteriz...
|
WO/2002/012206A1 |
The invention relates to a method for the production of melamine by pyrolysis of urea in a high pressure method, whereby urea, together with NH¿3?, is converted to melamine and the obtained melamine melt, together with additional urea, ...
|
WO/2002/008511A1 |
A method for the fluorescent whitening of cotton in a discontinuous process comprising contacting the cotton, I an aqueous bath having a pH value of 6 or less, with one or more compounds of the Formula (I) wherein R¿1? represents an -SO...
|
WO/2002/008222A2 |
Disclosed are a series of heteroaryl-$g(b)-alanine derivatives, compositions containing them, processes for their preparation and their use in medicine.
|
WO/2002/006251A1 |
The invention relates to compounds of formula (I) and to the salts thereof, wherein R?1¿ to R?4¿, A?1¿, A?2¿, L?0¿, X and n are defined as in claim 1. The inventive compounds are useful as herbicides and plant growth regulators and ...
|
WO/2002/004430A1 |
A process of preparing 4,6-dialkoxy-1,3,5-triazine-2- halide by reacting a cyanuric halide with an alcohol such as methanol in the presence of an alkali such as sodium hydrogencarbonate, characterized in that the amount of water present ...
|
WO/2002/002535A1 |
The present invention relates to a vertical multitubular gaslift reactor for the production of melamine from urea at high pressure, said reactor comprising: a first lower zone (1) comprising a urea inlet (2) for molten urea and an ammoni...
|
WO/2001/098281A1 |
The invention relates to an HD complete method for the continuous production of pure to highly pure melamine by non-catalytic pyrolysis of urea. According to this method, the melamine device no longer requires any feedback to the urea de...
|
WO/2001/095856A2 |
The present invention relates to a novel urea derivative which is useful as an anti-cancer agent, its pharmaceutically acceptable acid addition salt or stereoisomer, and to a process for preparing the urea derivative and an anti-cancer c...
|
WO/2001/096317A1 |
The present invention relates to a photosensitive composition, and provides a triazine-based compound comprising new functionalized alkylthio groups of which long term storage characteristics at room temperature as well as photochemical ...
|
WO/2001/092236A1 |
The invention relates to 4-alkyl halide triazine compounds of the general formula (I): wherein the variables R?1¿, R?2¿, R?3¿, R?4¿, A, X, Y, Hal, n and R are defined as per claim 1 and to use of said compounds as herbicides.
|
WO/2001/090079A2 |
The invention relates to carbamate and carbamide derivatives of formula (I), wherein the substituents have the meaning cited in the description. The invention also relates to the production and use thereof as endothelin receptor antagoni...
|
WO/2001/090085A2 |
The invention relates to 4-haloalkyltriazine compounds of general formula (I), where R?1¿, R?2¿, R?3¿, R?4¿, A, X, and Ar have the meanings given in claim 1 and use of said compounds as herbicides.
|
WO/2001/085701A1 |
Amino-pyrimidine and amino-triazine derivatives having 5-HT¿7? antagonist activity for the treatment of sleeping disorders, depression, schizophrenia, anxiety, obsessive compulsive disorders, circadian rhythm disorders, ocular disorders...
|
WO/2001/085700A2 |
This invention concerns HIV replication inhibitors of formula (I)the N-oxides, the pharmaceutically acceptable addition salts, the quaternary amines and the stereochemically isomeric forms thereof, provided that when Q is halo then Z is ...
|
WO/2001/077088A1 |
A methanesulfonic acid melam which can be advantageously used as a flame retardant for synthetic resins, especially polyamide resins; and a flame-retardant polyamide resin composition containing the methanesulfonic acid melam. The methan...
|
WO/2001/072722A1 |
A process for producing melamine crystals at high pureness is distinguished by the fact that it comprises a crystallisation step of a flow comprising substantially pure melt melamine by cooling with liquid ammonia and a thickening step o...
|
WO/2001/072715A2 |
The present invention provides heterocyclic vinylic compounds that can be used to form biocidal polymers. The polymers thus generated can used alone or can be grafted onto textiles, fabrics and polymers. The polymers are readily converte...
|
WO/2001/068516A1 |
The present invention relates to a composition capable of hydrogen sorption in a closed container at low pressure, comprising an usaturated organic substance and a hydrogenation catalyst. Said unsaturated organic substance is a compound ...
|
WO/2001/068616A1 |
The invention relates to novel, substituted 1-aryl-cyclopropylamino-1,3,5-triazines of the general formula (I), wherein the groups R?1¿, R?2¿, R?3¿ and Ar are defined as in the description. The invention further relates to a method an...
|
WO/2001/068612A2 |
This invention relates aryl substituted pyridines, pyrimides, pyrazines and triazines of Formula (I): or a pharmaceutically acceptable salt, prodrug or solvate thereof, wherein A¿1?, A¿2?, A¿3?, R¿1?-R¿4?, X and Y are set in the spe...
|
WO/2001/066528A1 |
A method of improving the stability of a quaternary ammonium salt; and a process for efficiently producing the quaternary ammonium salt having improved stability.
|
WO/2001/066681A1 |
Described is the use of a laundry detergent that includes at least one optical brightener from the class of the stilbene compounds for the antimicrobial finishing of textile fibre materials, which comprises washing the fibre materials wi...
|
WO/2001/062821A1 |
The invention relates to metathesis polymers wherein an aromatic group that has UV-light absorbing properties is attached with a bridge group to the polymer. Also disclosed is a polymerisable composition comprising a catalytically effect...
|
WO/2001/060882A1 |
Crosslinker compositions consisting essentially of 50 to 95 weight percent monomeric C¿1? to C¿8? alkoxymethyl melamine derivatives containing not more than about 0.20 wt. % of imino (>N-H) groups. Such compositions further comprise 5 ...
|
WO/2001/057000A1 |
Process for preparing melamine from urea at elevated temperature and in the presence of a catalyst, in which a gaseous product stream is obtained which is contacted with a liquid coolant in a cooling zone and that the temperature in the ...
|
WO/2001/057051A1 |
Salt of a melamine condensation product and a phosphorus-containing acid, the phosphorus-containing acid being a monobasic phosphorus-containing acid. Further a method for the preparation of a phosphorus-containing salt of a melamine con...
|
WO/2001/056999A1 |
Process for preparing melamine from urea at elevated temperature and in the presence of a catalyst, in which a gaseous product stream is obtained which is contacted with a liquid coolant in a cooling zone and in which a proportion of the...
|
WO/2001/055122A1 |
. The invention concerns compounds of general formula (I) wherein: R1, R2, R3, R4, R5 and R6 are as defined in Claim 1. Said compounds are useful in the treatment of pathologies related to the insulin-resistance syndrome.
|
WO/2001/053276A1 |
A compound of formula (I) or (II), wherein X is hydrogen, halogen, alkyl, aralkyl,aryloxy, arylalkoxy or alkoxy, Y is hydrogen, halogen, alkyl, aralkyl, aryloxy, arylalkoxy or alkoxy, or formula (a) wherein A and B are different and one ...
|
WO/2001/053277A1 |
The invention concerns a method for cyclotrimerization of isocyanate functions by action of a catalyst based on quaternary ammonium or phosphonium. The invention is characterised in that said isocyanate functions are branched and said on...
|
WO/2001/047897A1 |
N-heterocyclic compounds that block cytokine production via inhibition of p38 kinase are disclosed. In one embodiment, compounds of the present invention are represented by Formula I. Methods of production, pharmaceutical compositions an...
|
WO/2001/047900A1 |
Mixtures of compounds comprising a compound G¿2? and at least one further compound from the group G¿0?, G¿1?, G¿3?, G¿4?, G¿5?, G¿6?, the compounds G¿0?-G¿6? each corresponding to formula (I) in which, in the compound G¿0?, the...
|
WO/2001/047921A1 |
Compounds that selectively inhibit inappropriate kinase activities and methods for their preparation are disclosed. In one embodiment, the compounds are represented by Formula (I). As selective inhibitors of inappropriate kinase activiti...
|
WO/2001/046159A2 |
The process to recover both melamine and oxyaminotriazines (OAT) from the mother liquors of melamine crystallisation comprising the following steps: a) addition to a melamine and OAT containing aqueous solution at high temperature of an ...
|
WO/2001/046160A1 |
The invention relates to a method for the production of compounds of formula (I), by reaction of compounds of formula (II), where Het, R?1¿, R?2¿ and R?4¿ have the meanings given in the description, with anhydrous hydrogen chloride, o...
|
WO/2001/046161A1 |
Water soluble, amphoteric optical brighteners (W) comprising at least one brightener-characteristic radical X which contain at least one anionic substituent and covalently linked over at least one tertiary amino group Z to at least one n...
|
WO/2001/044204A1 |
Disclosed are phenoxy and thiophenoxy acrylic acid compounds of general formula (I), wherein Z, V and W, independently from one another, mean oxygen or sulphur and Het stands for an unsaturated, five- or six-membered, heterocyclic radica...
|
WO/2001/044209A1 |
The invention describes fluorochemical triazine compounds, compositions containing the fluorochemical triazine compounds, the process for preparing the fluorochemical compounds and compositions, substrates treated with the fluorochemical...
|
WO/2001/044208A1 |
The invention relates to compounds of formula (I) and the salts thereof in the optically active form. The respective optically active compound is present as a pure stereo isomer (with R- or S-configuration) with regard to the configurati...
|
WO/2001/044210A1 |
The present invention provides new compounds having formula: wherein each R¿1? represents, independently, an allyl- or diallylamino residue; each R¿2? represents, independently, phenylamino which is unsubstituted or substituted by one ...
|
WO/2001/039778A2 |
The invention relates to the use of triazinones such as triazine-diones and triazine-triones for producing agents for treating animals for parasitic protozoans, especially preventatively. The invention also relates to said agents.
|
WO/2001/040218A1 |
The invention concerns cancer therapy and novel anti-cancer agents having a very particular mechanism. The invention also concerns novel chemical compounds and their therapeutic use in humans.
|